Mads Hald Andersen

Mads Hald Andersen

Clinical Professor

Member of:

    ORCID: 0000-0002-2914-9605

    Publication year:
    All
    1 - 10 out of 10Page size: 10
    1. 2017
    2. Published

      Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells

      Nastasi, C., Fredholm, S., Willerslev-Olsen, A., Hansen, M., Bonefeld, Charlotte Menne, Geisler, Carsten, Andersen, Mads Hald, Ødum, Niels & Woetmann, Anders , Dec 2017, In: Scientific Reports. 7, 10 p., 14516.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs

      Overgaard, N. H., Frøsig, T. M., Jakobsen, J. T., Buus, Søren, Andersen, Mads Hald & Jungersen, G., Oct 2017, In: Vaccine. 35, 42, p. 5629-5636 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

      Donia, M., Harbst, K., van Buuren, M., Kvistborg, P., Lindberg, M. F., Andersen, R., Idorn, M., Munir Ahmad, S., Ellebæk, E., Mueller, A., Fagone, P., Nicoletti, F., Libra, M., Lauss, M., Hadrup, S. R., Schmidt, H., Andersen, M. H., Thor Straten, P., Nilsson, J. A., Schumacher, T. N. & 3 others, Seliger, B., Jönsson, G. & Svane, Inge Marie, 1 Sep 2017, In: Cancer Research. 77, 17, p. 4562-4566 5 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      Cancer and autoimmunity

      Andersen, Mads Hald, Apr 2017, In: Seminars in Immunopathology. 39, 3, p. 241-243 3 p.

      Research output: Contribution to journal › Editorial › Research › peer-review

    6. Published

      Anti-regulatory T cells

      Andersen, Mads Hald, 2017, In: Seminars in Immunopathology. 39, 3, p. 317–326 10 p.

      Research output: Contribution to journal › Review › Research › peer-review

    7. Published

      Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma

      Nitschke, N. J., Bjoern, J., Iversen, T. Z., Andersen, Mads Hald & Svane, Inge Marie, 2017, In: Stem Cell Investigation. 4, 13 p., 77.

      Research output: Contribution to journal › Journal article › Research › peer-review

    8. Published

      Mikromiljøet som med- og modspiller i B-celle-non-Hodgkin-lymfomer

      Klausen, U., Andersen, Mads Hald & Pedersen, Lars Møller, 2017, In: Ugeskrift for Læger. 179, 5 p., V03170220.

      Research output: Contribution to journal › Journal article › Research › peer-review

    9. Published

      The JAK2V617F and CALR exon 9 mutations are shared immunogenic neoantigens in hematological malignancy

      Holmstrom, M. O., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2017, In: OncoImmunology. 6, 11, 3 p., e1358334.

      Research output: Contribution to journal › Journal article › Research › peer-review

    10. Published

      The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms

      Holmström, M. O., Hjortso, M. D., Ahmad, S. M., Met, Özcan, Martinenaite, E., Riley, C., Straten, P., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2017, In: Leukemia. 31, p. 495-498

      Research output: Contribution to journal › Letter › Research › peer-review

    11. Published

      The role of dendritic cells in cancer

      Hansen, M. & Andersen, Mads Hald, 2017, In: Seminars in Immunopathology. 39, 3, p. 307-316

      Research output: Contribution to journal › Review › Research › peer-review

    ID: 13571778